SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes

被引：4

作者：

Aguilera, Ximena ^{[1
]}

Hormazabal, Juan ^{[2
]}

Vial, Cecilia ^{[2
]}

Jimena Cortes, Lina ^{[2
]}

Gonzalez, Claudia ^{[1
]}

Rubilar, Paola ^{[1
]}

Apablaza, Mauricio ^{[3
]}

Ramirez-Santana, Muriel ^{[4
]}

Icaza, Gloria ^{[5
]}

Nunez-Franz, Loreto ^{[6
]}

Castillo-Laborde, Carla ^{[1
]}

Ramirez-Riffo, Carolina ^{[2
]}

Perez, Claudia ^{[7
]}

Quezada-Gate, Ruben ^{[4
]}

Said, Macarena ^{[6
]}

Vial, Pablo ^{[2
,8
]}

机构：

[1] Clin Alemana Univ Desarrollo, Ctr Epidemiol & Polit Salud, Fac Med, Av Plaza 680, Santiago 7610658, Chile

[2] Clin Alemana Univ Desarrollo, Inst Ciencias & Innovac Med, Fac Med, Av Plaza 680, Santiago 7610658, Chile

[3] Univ Desarrollo, Fac Gobierno, Av Plaza 680, Santiago 7610658, Chile

[4] Univ Catolica Norte, Fac Med, Publ Hlth Dept, Larrondo 1281, Coquimbo 1780000, Chile

[5] Univ Talca, Inst Matemat, Ave Uno Poniente 1141, Talca 3460000, Chile

[6] Univ Talca, Fac Ciencias Salud, Dept Salud Publ, Ave Uno Poniente 1141, Talca 3460000, Chile

[7] Clin Alemana Univ Desarrollo, Fac Med, Escuela Enfermeria, Av Plaza 680, Santiago 7610658, Chile

[8] Clin Alemana Santiago, Ave Vitacura 5951, Santiago 7650568, Chile

来源：

VACCINES | 2022年 / 10卷 / 07期

关键词：

neutralizing antibodies; vaccines; BNT162b2; CoronaVac; AZD1222; COVID-19; SARS-CoV-2; cross-sectional design; vaccine-preventable diseases; viruses; COVID-19; VACCINES; BNT162B2;

D O I：

10.3390/vaccines10071051

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Using levels of neutralizing antibodies (nAbs), we evaluate the successful Chilean SARS-CoV-2 vaccine campaign, which combines different vaccine technologies and heterologous boosters. From a population-based study performed in November 2021, we randomly selected 120 seropositive individuals, organized into six groups of positive samples (20 subjects each) according to natural infection history and the five most frequent vaccination schemes. We conclude that the booster dose, regardless of vaccine technology or natural infection, and mRNA vaccines significantly improve nAbs response.

引用

页数：7

共 50 条

[21] Hyperimmunized Chickens Produce Neutralizing Antibodies against SARS-CoV-2
Aston, Emily J.
Wallach, Michael G.
Narayanan, Aarthi
Egana-Labrin, Sofia
Gallardo, Rodrigo A.
VIRUSES-BASEL, 2022, 14 (07):
[22] Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2
Park, Jun-Gyu
Oladunni, Fatai S.
Chiem, Kevin
Ye, Chengjin
Pipenbrink, Michael
Moran, Thomas
Walter, Mark R.
Kobie, James
Martinez-Sobrido, Luis
JOURNAL OF VIROLOGICAL METHODS, 2021, 287
[23] Systemic Neutralizing Antibodies and Local Immune Responses Are Critical for the Control of SARS-CoV-2
Chandrasekar, Shaswath S.
Phanse, Yashdeep
Riel, Mariah
Hildebrand, Rachel E.
Hanafy, Mostafa
Osorio, Jorge E.
Abdelgayed, Sherein S.
Talaat, Adel M.
VIRUSES-BASEL, 2022, 14 (06):
[24] Non-neutralizing antibodies: Deleterious or propitious during SARS-CoV-2 infection?
Zanella, Isabella
Degli Antoni, Melania
Marchese, Valentina
Castelli, Francesco
Quiros-Roldan, Eugenia
INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 110
[25] Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans
Haveri, Anu
Ekstrom, Nina
Solastie, Anna
Virta, Camilla
Osterlund, Pamela
Isosaari, Elina
Nohynek, Hanna
Palmu, Arto A.
Melin, Merit
EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 (12) : 3202 - 3213
[26] Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
Fendler, Annika
Shepherd, Scott T. C.
Au, Lewis
Wilkinson, Katalin A.
Wu, Mary
Byrne, Fiona
Cerrone, Maddalena
Schmitt, Andreas M.
Joharatnam-Hogan, Nalinie
Shum, Benjamin
Tippu, Zayd
Rzeniewicz, Karolina
Boos, Laura Amanda
Harvey, Ruth
Carlyle, Eleanor
Edmonds, Kim
Del Rosario, Lyra
Sarker, Sarah
Lingard, Karla
Mangwende, Mary
Holt, Lucy
Ahmod, Hamid
Korteweg, Justine
Foley, Tara
Bazin, Jessica
Gordon, William
Barber, Taja
Emslie-Henry, Andrea
Xie, Wenyi
Gerard, Camille L.
Deng, Daqi
Wall, Emma C.
Agua-Doce, Ana
Namjou, Sina
Caidan, Simon
Gavrielides, Mike
MacRae, James, I
Kelly, Gavin
Peat, Kema
Kelly, Denise
Murra, Aida
Kelly, Kayleigh
O'Flaherty, Molly
Dowdie, Lauren
Ash, Natalie
Gronthoud, Firza
Shea, Robyn L.
Gardner, Gail
Murray, Darren
Kinnaird, Fiona
NATURE CANCER, 2021, 2 (12) : 1305 - 1320
[27] Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination
da Silva, Almir Ribeiro, Jr.
Villas-Boas, Lucy Santos
Tozetto-Mendoza, Tania Regina
Honorato, Layla
de Paula, Anderson
Witkin, Steven S.
Mendes-Correa, Maria Cassia
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2022, 64
[28] The persistence of SARS-CoV-2 neutralizing antibodies after COVID-19: A one-year observation. Is a SARS-CoV-2 vaccination booster dose necessary?
Tworek, Adam
Jaron, Krzysztof
Cicha, Malgorzata
Rydzewski, Andrzej
Wierzba, Waldemar
Zaczynski, Arturza
Krol, Zbigniew
Rydzewska, Grazyna
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 48 (02) : 92 - 96
[29] Induction of Neutralizing Antibodies in Chronic Lymphocytic Leukemia Patients After SARS-CoV-2 mRNA Vaccination: A Monocentric Experience
Mavilia, Fabrizio
Pratesi, Federico
Barate, Claudia
Benedetti, Edoardo
Guerri, Valentina
Sammuri, Paola
Migliorini, Paola
Galimberti, Sara
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S262 - S263
[30] BNT162b2 Vaccination after SARS-CoV-2 Infection Changes the Dynamics of Total and Neutralizing Antibodies against SARS-CoV-2: A 6-Month Prospective Cohort Study
Hernandez-Bello, Jorge
Sierra-Garcia-de-Quevedo, Jose Julio
Morales-Nunez, Jose Javier
Santoscoy-Ascencio, Guillermo
Diaz-Perez, Saul Alberto
Gutierrez-Brito, Jesus Alberto
Munoz-Valle, Jose Francisco
VACCINES, 2023, 11 (06)

← 1 2 3 4 5 →